Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
36.99
+0.79 (2.18%)
At close: Jul 3, 2025, 1:00 PM
36.95
-0.04 (-0.11%)
After-hours: Jul 3, 2025, 4:55 PM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $1.62 billion as of July 3, 2025.
Market Cap
1.62B
Enterprise Value
1.61B
1-Year Change
n/a
Ranking
Category
Stock Price
36.99
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $1.62B, an increase of 639.80%. That is a compound annual growth rate of 23,200.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 3, 2025 | 1.62B | 2.18% |
Jul 2, 2025 | 1.59B | 15.14% |
Jul 1, 2025 | 1.38B | -0.69% |
Jun 30, 2025 | 1.39B | 1.44% |
Jun 27, 2025 | 1.37B | -7.22% |
Jun 26, 2025 | 1.48B | 5.69% |
Jun 25, 2025 | 1.40B | 32.18% |
Jun 24, 2025 | 1.06B | 27.75% |
Jun 23, 2025 | 827.35M | 17.08% |
Jun 20, 2025 | 706.65M | 39.27% |
Jun 18, 2025 | 507.38M | 16.18% |
Jun 17, 2025 | 436.72M | 10.43% |
Jun 16, 2025 | 395.46M | 4.04% |
Jun 13, 2025 | 380.10M | -1.59% |
Jun 12, 2025 | 386.24M | 1.44% |
Jun 11, 2025 | 380.76M | 0.17% |
Jun 10, 2025 | 380.10M | 2.85% |
Jun 9, 2025 | 369.56M | -1.75% |
Jun 6, 2025 | 376.15M | 2.51% |
Jun 5, 2025 | 366.93M | -0.59% |
Jun 4, 2025 | 369.12M | 2.58% |
Jun 3, 2025 | 359.84M | 3.58% |
Jun 2, 2025 | 347.40M | 0.57% |
May 30, 2025 | 345.42M | 1.55% |
May 29, 2025 | 340.16M | 0.32% |
May 28, 2025 | 339.06M | 0.85% |
May 27, 2025 | 336.21M | -0.52% |
May 23, 2025 | 337.96M | -0.65% |
May 22, 2025 | 340.16M | -0.64% |
May 21, 2025 | 342.35M | -2.50% |
May 20, 2025 | 351.13M | 6.10% |
May 19, 2025 | 330.94M | - |
May 16, 2025 | 330.94M | 1.07% |
May 15, 2025 | 327.43M | 6.12% |
May 14, 2025 | 308.56M | -0.85% |
May 13, 2025 | 311.19M | 3.96% |
May 12, 2025 | 299.34M | 6.07% |
May 9, 2025 | 282.22M | -3.02% |
May 8, 2025 | 291.00M | 1.53% |
May 7, 2025 | 286.61M | -0.61% |
May 6, 2025 | 288.37M | 4.12% |
May 5, 2025 | 276.95M | -1.87% |
May 2, 2025 | 282.22M | 2.23% |
May 1, 2025 | 276.08M | 3.11% |
Apr 30, 2025 | 267.74M | -5.13% |
Apr 29, 2025 | 282.22M | - |
Apr 28, 2025 | 282.22M | -1.53% |
Apr 25, 2025 | 286.61M | -2.54% |
Apr 24, 2025 | 294.07M | -2.19% |
Apr 23, 2025 | 300.65M | -0.58% |
Apr 22, 2025 | 302.41M | 3.77% |
Apr 21, 2025 | 291.44M | 0.45% |
Apr 17, 2025 | 290.12M | 0.61% |
Apr 16, 2025 | 288.37M | 2.98% |
Apr 15, 2025 | 280.03M | -0.47% |
Apr 14, 2025 | 281.34M | 1.91% |
Apr 11, 2025 | 276.08M | 3.11% |
Apr 10, 2025 | 267.74M | -1.29% |
Apr 9, 2025 | 271.25M | -5.21% |
Apr 8, 2025 | 286.17M | -9.13% |
Apr 7, 2025 | 314.92M | -0.62% |
Apr 4, 2025 | 316.89M | -0.69% |
Apr 3, 2025 | 319.09M | 3.86% |
Apr 2, 2025 | 307.24M | -3.71% |
Apr 1, 2025 | 319.09M | -2.55% |
Mar 31, 2025 | 327.43M | -1.19% |
Mar 28, 2025 | 331.38M | 1.89% |
Mar 27, 2025 | 325.23M | -0.87% |
Mar 26, 2025 | 328.09M | 1.01% |
Mar 25, 2025 | 324.79M | -1.60% |
Mar 24, 2025 | 330.06M | -0.53% |
Mar 21, 2025 | 331.82M | 0.93% |
Mar 20, 2025 | 328.75M | 4.46% |
Mar 19, 2025 | 314.70M | 3.91% |
Mar 18, 2025 | 302.85M | -1.29% |
Mar 17, 2025 | 306.80M | -2.24% |
Mar 14, 2025 | 313.82M | 4.99% |
Mar 13, 2025 | 298.90M | 1.95% |
Mar 12, 2025 | 293.19M | -4.02% |
Mar 11, 2025 | 305.48M | 12.08% |
Mar 10, 2025 | 272.56M | -10.39% |
Mar 7, 2025 | 304.17M | -3.48% |
Mar 6, 2025 | 315.14M | 1.70% |
Mar 5, 2025 | 309.87M | 9.29% |
Mar 4, 2025 | 283.54M | -4.44% |
Mar 3, 2025 | 296.70M | 1.05% |
Feb 28, 2025 | 293.63M | 5.35% |
Feb 27, 2025 | 278.71M | -0.47% |
Feb 26, 2025 | 280.03M | 4.08% |
Feb 25, 2025 | 269.05M | -1.45% |
Feb 24, 2025 | 273.00M | 7.80% |
Feb 21, 2025 | 253.25M | 1.76% |
Feb 20, 2025 | 248.86M | 13.40% |
Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 700.84B |
Johnson & Johnson | 375.37B |
AbbVie | 334.34B |
Novo Nordisk | 306.47B |
UnitedHealth Group | 279.90B |
Novartis AG | 238.56B |
Abbott Laboratories | 233.90B |
AstraZeneca | 216.08B |